What if people could stay healthier, stronger, and mentally sharper as they grow older—not by treating diseases one by one but by slowing a biological process that drives aging itself? A new University of Rochester–led research effort will test whether a drug originally developed to treat HIV can quiet a chronic immune response triggered by the body’s own DNA, to help preserve overall health and function later in life. The project is supported by a contract of up to $22 million over five years from the Advanced Research Projects Agency for Health (ARPA-H) and includes collaborators from Brown University, University of Connecticut, The University of Texas Medical Branch, University of Texas Health Houston, University of Nebraska, and Transposon Therapeutics.

A new study sheds light on the behavior of yeast cells in the gut, paving the way for new lines of yeast that more efficiently produce therapeutic drugs tailored to address specific diseases.

With children across the U.S. facing long wait times for medical care due to a shortage of pediatricians, UC San Francisco has launched a medical education program designed to strengthen the pediatric workforce and improve childhood health outcomes.